Benzinga | Dec 15, 2020 01:24PM EST

Morgan Stanley Maintains Overweight on Zimmer Biomet Holdings, Raises Price Target to $170

Morgan Stanley maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Overweight and raises the price target from $150 to $170.